Skip to content
10-Q

Quarterly Report

Corvus Pharmaceuticals, Inc. CRVS

0001104659-25-106259

← back to feed
Filed
Nov 4, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Nov 4, 2025 74.68M sh
Shares Diluted Q3 2025 · Sep 30, 2025 82.84M sh
Shares Diluted Q3 2025 · Sep 30, 2025 78.66M sh
Shares Diluted Q3 2025 · Sep 30, 2024 66.7M sh
Shares Diluted Q3 2025 · Sep 30, 2024 58.51M sh
Capex Q3 2025 · Sep 30, 2025 $149K
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$23.61M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$16.96M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $2.87M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $8.74M
Stockholders Equity Q3 2025 · Sep 30, 2025 $71.77M
Stockholders Equity Q3 2025 · Jun 30, 2025 $80.23M
Stockholders Equity Q3 2025 · Mar 31, 2025 $49.33M
Stockholders Equity Q3 2025 · Dec 31, 2024 $32.57M
Stockholders Equity Q3 2025 · Sep 30, 2024 $12.41M
Stockholders Equity Q3 2025 · Jun 30, 2024 $51.23M
Stockholders Equity Q3 2025 · Mar 31, 2024 $33.36M
Stockholders Equity Q3 2025 · Dec 31, 2023 $38.68M
Current Liabilities Q3 2025 · Sep 30, 2025 $8.07M
Current Liabilities Q3 2025 · Dec 31, 2024 $35.4M
Total Liabilities Q3 2025 · Sep 30, 2025 $8.71M
Total Liabilities Q3 2025 · Dec 31, 2024 $36.34M
Current Assets Q3 2025 · Sep 30, 2025 $66.94M
Current Assets Q3 2025 · Dec 31, 2024 $54.41M
Total Assets Q3 2025 · Sep 30, 2025 $80.47M
Total Assets Q3 2025 · Dec 31, 2024 $68.91M
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.12
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.38
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.60
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.86
Eps Basic Q3 2025 · Sep 30, 2025 −$0.12
Eps Basic Q3 2025 · Sep 30, 2025 −$0.04
Eps Basic Q3 2025 · Sep 30, 2024 −$0.60
Eps Basic Q3 2025 · Sep 30, 2024 −$0.86
Sga Expense Q3 2025 · Sep 30, 2025 $2.12M
Sga Expense Q3 2025 · Sep 30, 2025 $6.97M
Sga Expense Q3 2025 · Sep 30, 2024 $2.03M
Sga Expense Q3 2025 · Sep 30, 2024 $6.03M
Rd Expense Q3 2025 · Sep 30, 2025 $8.45M
Rd Expense Q3 2025 · Sep 30, 2025 $23.78M
Rd Expense Q3 2025 · Sep 30, 2024 $5.22M
Rd Expense Q3 2025 · Sep 30, 2024 $13.41M
Net Income Q3 2025 · Sep 30, 2025 −$10.16M
Net Income Q3 2025 · Sep 30, 2025 −$2.96M
Net Income Q3 2025 · Jun 30, 2025 −$8M
Net Income Q3 2025 · Mar 31, 2025 $15.19M
Net Income Q3 2025 · Sep 30, 2024 −$40.22M
Net Income Q3 2025 · Sep 30, 2024 −$50.18M
Net Income Q3 2025 · Jun 30, 2024 −$4.26M
Net Income Q3 2025 · Mar 31, 2024 −$5.7M
Operating Income Q3 2025 · Sep 30, 2025 −$10.57M
Operating Income Q3 2025 · Sep 30, 2025 −$30.75M
Operating Income Q3 2025 · Sep 30, 2024 −$7.26M
Operating Income Q3 2025 · Sep 30, 2024 −$19.44M